Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8158 |
Intermediate Similarity |
NPD7236 |
Approved |
0.811 |
Intermediate Similarity |
NPD7799 |
Discontinued |
0.8013 |
Intermediate Similarity |
NPD7239 |
Suspended |
0.7952 |
Intermediate Similarity |
NPD8470 |
Clinical (unspecified phase) |
0.7823 |
Intermediate Similarity |
NPD5952 |
Clinical (unspecified phase) |
0.7706 |
Intermediate Similarity |
NPD8368 |
Discontinued |
0.7674 |
Intermediate Similarity |
NPD8407 |
Phase 2 |
0.7669 |
Intermediate Similarity |
NPD7057 |
Phase 3 |
0.7669 |
Intermediate Similarity |
NPD7058 |
Phase 2 |
0.7619 |
Intermediate Similarity |
NPD6007 |
Clinical (unspecified phase) |
0.7529 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7399 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7379 |
Intermediate Similarity |
NPD5125 |
Phase 3 |
0.7379 |
Intermediate Similarity |
NPD5126 |
Approved |
0.7329 |
Intermediate Similarity |
NPD6273 |
Approved |
0.732 |
Intermediate Similarity |
NPD7966 |
Clinical (unspecified phase) |
0.7303 |
Intermediate Similarity |
NPD8435 |
Approved |
0.7303 |
Intermediate Similarity |
NPD8360 |
Approved |
0.7303 |
Intermediate Similarity |
NPD8361 |
Approved |
0.7288 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7278 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7241 |
Intermediate Similarity |
NPD7741 |
Discontinued |
0.7233 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7203 |
Intermediate Similarity |
NPD2629 |
Approved |
0.7191 |
Intermediate Similarity |
NPD8424 |
Clinical (unspecified phase) |
0.7169 |
Intermediate Similarity |
NPD37 |
Approved |
0.7143 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7143 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7143 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7112 |
Intermediate Similarity |
NPD7497 |
Discontinued |
0.7102 |
Intermediate Similarity |
NPD6765 |
Approved |
0.7102 |
Intermediate Similarity |
NPD6764 |
Approved |
0.7095 |
Intermediate Similarity |
NPD7457 |
Clinical (unspecified phase) |
0.7076 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7059 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7048 |
Intermediate Similarity |
NPD7028 |
Phase 2 |
0.7043 |
Intermediate Similarity |
NPD8486 |
Clinical (unspecified phase) |
0.7034 |
Intermediate Similarity |
NPD4198 |
Discontinued |
0.7033 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7032 |
Intermediate Similarity |
NPD7961 |
Discontinued |
0.7029 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7024 |
Intermediate Similarity |
NPD5760 |
Phase 2 |
0.7024 |
Intermediate Similarity |
NPD5761 |
Phase 2 |
0.7013 |
Intermediate Similarity |
NPD7008 |
Discontinued |
0.7006 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.6975 |
Remote Similarity |
NPD6190 |
Approved |
0.6971 |
Remote Similarity |
NPD7228 |
Approved |
0.6944 |
Remote Similarity |
NPD6784 |
Approved |
0.6944 |
Remote Similarity |
NPD6785 |
Approved |
0.6939 |
Remote Similarity |
NPD7516 |
Approved |
0.6937 |
Remote Similarity |
NPD7266 |
Discontinued |
0.6937 |
Remote Similarity |
NPD5763 |
Approved |
0.6937 |
Remote Similarity |
NPD5762 |
Approved |
0.6927 |
Remote Similarity |
NPD8312 |
Approved |
0.6927 |
Remote Similarity |
NPD8313 |
Approved |
0.6923 |
Remote Similarity |
NPD2181 |
Clinical (unspecified phase) |
0.6923 |
Remote Similarity |
NPD6663 |
Approved |
0.6906 |
Remote Similarity |
NPD8150 |
Discontinued |
0.6901 |
Remote Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.6897 |
Remote Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.6887 |
Remote Similarity |
NPD7507 |
Approved |
0.6886 |
Remote Similarity |
NPD7458 |
Discontinued |
0.6883 |
Remote Similarity |
NPD5736 |
Approved |
0.6882 |
Remote Similarity |
NPD8485 |
Approved |
0.6871 |
Remote Similarity |
NPD7328 |
Approved |
0.6871 |
Remote Similarity |
NPD7327 |
Approved |
0.6863 |
Remote Similarity |
NPD7319 |
Approved |
0.6859 |
Remote Similarity |
NPD3764 |
Approved |
0.6849 |
Remote Similarity |
NPD5951 |
Approved |
0.6848 |
Remote Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.6848 |
Remote Similarity |
NPD8389 |
Clinical (unspecified phase) |
0.6846 |
Remote Similarity |
NPD7503 |
Approved |
0.6845 |
Remote Similarity |
NPD4380 |
Phase 2 |
0.6842 |
Remote Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.6832 |
Remote Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.6832 |
Remote Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.6832 |
Remote Similarity |
NPD6005 |
Phase 3 |
0.6832 |
Remote Similarity |
NPD6002 |
Phase 3 |
0.6832 |
Remote Similarity |
NPD6004 |
Phase 3 |
0.6828 |
Remote Similarity |
NPD7094 |
Approved |
0.6828 |
Remote Similarity |
NPD6858 |
Approved |
0.6824 |
Remote Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.6824 |
Remote Similarity |
NPD8455 |
Phase 2 |
0.6824 |
Remote Similarity |
NPD7819 |
Suspended |
0.6816 |
Remote Similarity |
NPD7240 |
Approved |
0.681 |
Remote Similarity |
NPD8166 |
Discontinued |
0.681 |
Remote Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.6802 |
Remote Similarity |
NPD7075 |
Discontinued |
0.68 |
Remote Similarity |
NPD3412 |
Clinical (unspecified phase) |
0.6786 |
Remote Similarity |
NPD6591 |
Clinical (unspecified phase) |
0.6783 |
Remote Similarity |
NPD2182 |
Approved |
0.678 |
Remote Similarity |
NPD3818 |
Discontinued |
0.6774 |
Remote Similarity |
NPD6535 |
Approved |
0.6774 |
Remote Similarity |
NPD6534 |
Approved |
0.6772 |
Remote Similarity |
NPD4140 |
Approved |
0.6768 |
Remote Similarity |
NPD7274 |
Clinical (unspecified phase) |
0.6766 |
Remote Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.6761 |
Remote Similarity |
NPD6685 |
Approved |
0.6746 |
Remote Similarity |
NPD6599 |
Discontinued |
0.6739 |
Remote Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.6735 |
Remote Similarity |
NPD8462 |
Phase 1 |
0.6711 |
Remote Similarity |
NPD7610 |
Discontinued |
0.6704 |
Remote Similarity |
NPD7074 |
Phase 3 |
0.669 |
Remote Similarity |
NPD4141 |
Clinical (unspecified phase) |
0.6687 |
Remote Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.6686 |
Remote Similarity |
NPD5402 |
Approved |
0.6686 |
Remote Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.6685 |
Remote Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.6667 |
Remote Similarity |
NPD6801 |
Discontinued |
0.6667 |
Remote Similarity |
NPD7009 |
Phase 2 |
0.6667 |
Remote Similarity |
NPD5537 |
Clinical (unspecified phase) |
0.6667 |
Remote Similarity |
NPD7435 |
Discontinued |
0.6667 |
Remote Similarity |
NPD7699 |
Phase 2 |
0.6667 |
Remote Similarity |
NPD6831 |
Clinical (unspecified phase) |
0.6667 |
Remote Similarity |
NPD7700 |
Phase 2 |
0.6648 |
Remote Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.6648 |
Remote Similarity |
NPD6232 |
Discontinued |
0.6648 |
Remote Similarity |
NPD7054 |
Approved |
0.6645 |
Remote Similarity |
NPD3094 |
Phase 2 |
0.6632 |
Remote Similarity |
NPD8319 |
Approved |
0.6632 |
Remote Similarity |
NPD8320 |
Phase 1 |
0.6629 |
Remote Similarity |
NPD7473 |
Discontinued |
0.6629 |
Remote Similarity |
NPD5494 |
Approved |
0.6628 |
Remote Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.6626 |
Remote Similarity |
NPD7702 |
Clinical (unspecified phase) |
0.6626 |
Remote Similarity |
NPD2346 |
Discontinued |
0.6625 |
Remote Similarity |
NPD230 |
Phase 1 |
0.6625 |
Remote Similarity |
NPD6355 |
Discontinued |
0.6623 |
Remote Similarity |
NPD8378 |
Approved |
0.6623 |
Remote Similarity |
NPD8380 |
Approved |
0.6623 |
Remote Similarity |
NPD8335 |
Approved |
0.6623 |
Remote Similarity |
NPD8379 |
Approved |
0.6623 |
Remote Similarity |
NPD8296 |
Approved |
0.6623 |
Remote Similarity |
NPD8033 |
Approved |
0.6622 |
Remote Similarity |
NPD690 |
Clinical (unspecified phase) |
0.6611 |
Remote Similarity |
NPD7472 |
Approved |
0.6606 |
Remote Similarity |
NPD4110 |
Phase 3 |
0.6606 |
Remote Similarity |
NPD7003 |
Approved |
0.6606 |
Remote Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.6606 |
Remote Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.6605 |
Remote Similarity |
NPD2799 |
Discontinued |
0.6603 |
Remote Similarity |
NPD5740 |
Clinical (unspecified phase) |
0.6603 |
Remote Similarity |
NPD6085 |
Phase 2 |
0.6601 |
Remote Similarity |
NPD6287 |
Discontinued |
0.6597 |
Remote Similarity |
NPD6782 |
Approved |
0.6597 |
Remote Similarity |
NPD6780 |
Approved |
0.6597 |
Remote Similarity |
NPD6686 |
Approved |
0.6597 |
Remote Similarity |
NPD6781 |
Approved |
0.6597 |
Remote Similarity |
NPD6776 |
Approved |
0.6597 |
Remote Similarity |
NPD6779 |
Approved |
0.6597 |
Remote Similarity |
NPD6778 |
Approved |
0.6597 |
Remote Similarity |
NPD6777 |
Approved |
0.6592 |
Remote Similarity |
NPD3751 |
Discontinued |
0.659 |
Remote Similarity |
NPD3817 |
Phase 2 |
0.6584 |
Remote Similarity |
NPD6653 |
Approved |
0.6579 |
Remote Similarity |
NPD7163 |
Clinical (unspecified phase) |
0.6575 |
Remote Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.6575 |
Remote Similarity |
NPD6797 |
Phase 2 |
0.657 |
Remote Similarity |
NPD1934 |
Approved |
0.6568 |
Remote Similarity |
NPD5403 |
Approved |
0.6564 |
Remote Similarity |
NPD2935 |
Discontinued |
0.6556 |
Remote Similarity |
NPD8294 |
Approved |
0.6556 |
Remote Similarity |
NPD8377 |
Approved |
0.6554 |
Remote Similarity |
NPD3787 |
Discontinued |
0.6549 |
Remote Similarity |
NPD5765 |
Approved |
0.6548 |
Remote Similarity |
NPD2533 |
Approved |
0.6548 |
Remote Similarity |
NPD2534 |
Approved |
0.6548 |
Remote Similarity |
NPD2532 |
Approved |
0.6548 |
Remote Similarity |
NPD5401 |
Approved |
0.6545 |
Remote Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.6543 |
Remote Similarity |
NPD7097 |
Phase 1 |
0.6538 |
Remote Similarity |
NPD7251 |
Discontinued |
0.6531 |
Remote Similarity |
NPD6912 |
Phase 3 |
0.6529 |
Remote Similarity |
NPD1653 |
Approved |
0.6528 |
Remote Similarity |
NPD6823 |
Phase 2 |
0.6522 |
Remote Similarity |
NPD5735 |
Approved |
0.6517 |
Remote Similarity |
NPD8404 |
Phase 2 |
0.6512 |
Remote Similarity |
NPD7411 |
Suspended |
0.6506 |
Remote Similarity |
NPD3750 |
Approved |
0.6503 |
Remote Similarity |
NPD164 |
Approved |
0.6503 |
Remote Similarity |
NPD7305 |
Phase 1 |
0.6503 |
Remote Similarity |
NPD7808 |
Phase 3 |
0.6494 |
Remote Similarity |
NPD3092 |
Approved |
0.6491 |
Remote Similarity |
NPD3226 |
Approved |
0.6488 |
Remote Similarity |
NPD6799 |
Approved |
0.648 |
Remote Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.648 |
Remote Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.648 |
Remote Similarity |
NPD6166 |
Phase 2 |
0.6467 |
Remote Similarity |
NPD6009 |
Approved |
0.6465 |
Remote Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.6465 |
Remote Similarity |
NPD7874 |
Approved |
0.6463 |
Remote Similarity |
NPD2438 |
Suspended |
0.646 |
Remote Similarity |
NPD3619 |
Clinical (unspecified phase) |
0.646 |
Remote Similarity |
NPD3620 |
Phase 2 |
0.6455 |
Remote Similarity |
NPD6214 |
Clinical (unspecified phase) |
0.6455 |
Remote Similarity |
NPD6212 |
Phase 3 |
0.6455 |
Remote Similarity |
NPD6213 |
Phase 3 |
0.6454 |
Remote Similarity |
NPD1238 |
Approved |
0.6447 |
Remote Similarity |
NPD9545 |
Approved |
0.6447
|
Remote Similarity |
NPD6319 |
Approved |